HK1185230A1 - Composition comprising imidazole peptide and quercetin glycoside - Google Patents

Composition comprising imidazole peptide and quercetin glycoside

Info

Publication number
HK1185230A1
HK1185230A1 HK13112868.9A HK13112868A HK1185230A1 HK 1185230 A1 HK1185230 A1 HK 1185230A1 HK 13112868 A HK13112868 A HK 13112868A HK 1185230 A1 HK1185230 A1 HK 1185230A1
Authority
HK
Hong Kong
Prior art keywords
composition
quercetin glycoside
imidazole peptide
imidazole
peptide
Prior art date
Application number
HK13112868.9A
Other languages
Chinese (zh)
Inventor
Nozomi Kitahara
Aki Tsujimoto
Original Assignee
Suntory Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Holdings Ltd filed Critical Suntory Holdings Ltd
Publication of HK1185230A1 publication Critical patent/HK1185230A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/86—Addition of bitterness inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
HK13112868.9A 2012-03-08 2013-11-18 Composition comprising imidazole peptide and quercetin glycoside HK1185230A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2012051946 2012-03-08

Publications (1)

Publication Number Publication Date
HK1185230A1 true HK1185230A1 (en) 2014-02-14

Family

ID=49116178

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13112868.9A HK1185230A1 (en) 2012-03-08 2013-11-18 Composition comprising imidazole peptide and quercetin glycoside

Country Status (5)

Country Link
JP (1) JP5324000B1 (en)
CN (1) CN103300278B (en)
HK (1) HK1185230A1 (en)
TW (1) TWI517793B (en)
WO (1) WO2013132668A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014267299B2 (en) 2013-05-14 2019-07-18 Mars, Incorporated Joint care composition
JP6310708B2 (en) * 2014-01-28 2018-04-11 花王株式会社 Solid composition
GB201414910D0 (en) * 2014-05-23 2014-10-08 Mars Inc Composition
JP6676292B2 (en) * 2015-06-23 2020-04-08 三栄源エフ・エフ・アイ株式会社 Oral composition
EP3442517A1 (en) * 2016-04-14 2019-02-20 Lucey, Michael Combinational compositions and methods of use thereof
JP7134607B2 (en) * 2016-08-25 2022-09-12 大正製薬株式会社 tablet
JP2018090640A (en) * 2018-03-16 2018-06-14 花王株式会社 Solid composition
CN108926506B (en) * 2018-09-27 2022-02-25 中国农业科学院麻类研究所 Method for extracting flavonol components in jute leaves, extract and application thereof
US20220183338A1 (en) * 2019-02-20 2022-06-16 Suntory Holdings Limited Protein-containing oral composition and method for improving flavor of protein-containing oral composition
AU2020406604A1 (en) * 2019-12-17 2022-07-07 Suntory Holdings Limited Composition for promoting chondroitin sulfate synthesis
JP6956846B1 (en) * 2020-12-17 2021-11-02 ダイドーグループホールディングス株式会社 Low back pain improver and trunk muscle strength improver
JP7080388B1 (en) 2021-10-29 2022-06-03 ダイドーグループホールディングス株式会社 An agent for improving dynamic balance in gait function, an agent for reducing anxiety about falls, and an agent for improving gait function for people with decreased mobility.

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01110616A (en) * 1987-10-22 1989-04-27 Naoki Suzuki Bath agent
EP0565313B1 (en) * 1992-04-02 1997-07-30 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Method to improve taste preference of pine extract, and orally administrable product obtained thereby
JPH07265008A (en) * 1994-03-29 1995-10-17 Ajinomoto Co Inc Agent for imparting good body
JPH0899861A (en) * 1994-09-30 1996-04-16 Kose Corp Skin external agent
DE4444238A1 (en) * 1994-12-13 1996-06-20 Beiersdorf Ag Cosmetic or dermatological drug combinations of cinnamic acid derivatives and flavone glycosides
JP3416104B2 (en) * 1999-12-20 2003-06-16 雪印食品株式会社 Method for enhancing antioxidant ability of food and antioxidant enhancer for food
JP2002101843A (en) * 2000-10-02 2002-04-09 Ajinomoto Co Inc Sweetener composition for boiled food
JP2004059522A (en) * 2002-07-30 2004-02-26 Fancl Corp Long-acting rutin preparation
JP2005006615A (en) * 2003-06-17 2005-01-13 Crescendo Corporation Chabushi
JP2006158274A (en) * 2004-12-06 2006-06-22 National Agriculture & Food Research Organization Sprout using f. tataricum grain
JP4635159B2 (en) * 2005-09-05 2011-02-16 独立行政法人農業・食品産業技術総合研究機構 Edible plant body containing GABA in high concentration and method for producing the same
US20080193591A1 (en) * 2005-12-26 2008-08-14 Yaizu Suisankagaku Industry Co., Ltd. Taste Improving Agent for Food and Beverage Containing Potassium Chloride, Process for Producing Food and Beverage Containing Potassium Chloride and Food and Beverage Containing Potassium Chloride Produced by the Process
JP2007197363A (en) * 2006-01-26 2007-08-09 Beta Shokuhin Kk Nutritional supplement
US20090214712A1 (en) * 2008-02-21 2009-08-27 The Coca Cola Company Milk-Based Beverage and Method for Preventing Off-Flavors in a Milk-Based Beverage
US20110124577A1 (en) * 2008-07-30 2011-05-26 Suntory Holdings Limited Preparation for oral administration comprises quercetin glycoside and a water-based solvent extract of cartilage containing chondroitin sulfate
CN103037710B (en) * 2010-04-15 2016-08-10 卓莫赛尔公司 For the compound of bitterness, compositions and method are reduced or eliminated

Also Published As

Publication number Publication date
JPWO2013132668A1 (en) 2015-07-30
WO2013132668A1 (en) 2013-09-12
JP5324000B1 (en) 2013-10-23
CN103300278A (en) 2013-09-18
TW201347681A (en) 2013-12-01
CN103300278B (en) 2015-01-28
TWI517793B (en) 2016-01-21

Similar Documents

Publication Publication Date Title
HUS2200034I1 (en) Glycoconjugation processes and compositions
HK1185230A1 (en) Composition comprising imidazole peptide and quercetin glycoside
IL238958A0 (en) Glutamase inhibitors, compositions comprising same and uses thereof
HK1214970A1 (en) Composition comprising fructooligosaccharide and quercetin glycoside
IL238959A0 (en) Glutamase inhibitors, compositions comprising same and uses thereof
IL269024A (en) Compositions comprising peg and ascorbate
IL236268A0 (en) Compositions for transmucosal delivery and uses thereof
EP2556430A4 (en) Virtual application extension points
IL232217A (en) Azole derivatives, pharmaceutical compositions comprising them and their uses
GB201314312D0 (en) Composition and delivery system
ZA201302113B (en) Caspofungin composition
EP2708532A4 (en) 4-aminoquinazoline derivatives and uses thereof
IL236712A0 (en) Di-and tri-heteroaryl derivatives, compositions comprising same and uses thereof
EP2889307A4 (en) Alpha-conotoxin peptide, and medical composition and purpose thereof
EP2874641A4 (en) Glutathione-elevating compositions and uses thereof
HK1204948A1 (en) Radiation-sterilization-resistant protein composition
HUE032878T2 (en) Dermo-protective and dermo-balancing composition
ZA201209745B (en) Compositions containing flavones and anthelmintics
TH1401005243B (en) Solid formulation containing imidazole peptide and quercetin glycoside.